Start with the answer that matters
MOTS-c belongs to a group called peptides, short strings of the same building blocks that make proteins.
The Food and Drug Administration (FDA) regulates drugs in the US; as of September 30, 2026, it had approved no MOTS-c product.
FDA’s review found no published studies of people receiving MOTS-c. A search on September 30, 2026, also found no published results from a MOTS-c treatment trial.
As of September 30, 2026, a MOTS-c trial was looking for people to join, but had no results to read. A completed study tested a changed version called CB4211, a different substance.
That leaves a practical question: what would a care service be relying on? Keep that question in view before comparing offers.
Mouse work
Lee’s mouse study found less weight gain and helped prevent the body becoming less able to control blood sugar.
Human treatment
As of September 30, 2026, there were no published MOTS-c treatment results in people.
US medicine
MOTS-c had no FDA approval as of September 30, 2026.
Pick the question on your mind
Choose whichever unanswered question is keeping you from deciding.
What am I looking at?
What MOTS-c is and why a shot needs its own evidence.
Open card The evidenceDoes it do what I hope?
Read the mouse findings and the human trial record.
Open card The rulesIs this a medicine I can get?
Approval, raw ingredients and the FDA review.
Open card The gapsWhat remains unknown?
The missing studies, personal health and sports rules.
Open card The careHow do I check an offer?
The assessment, the licence and follow-up questions.
Open card The costWhat am I paying for?
Get a full price quote and ask your insurance plan what it pays.
Open cardMake the next conversation useful
Begin with your goal, such as a concern about weight or energy. Ask a licensed doctor to look into that concern, explain the options and say which studies support each one.
Collect the questions you want to bring into that conversation.
Keep this in mind
A real peptide and an approved treatment are different things; MOTS-c has no US drug approval as of September 30, 2026.
A question to take
What human evidence supports MOTS-c for the problem I want help with?
Open my notes